Scrutinizer's Report filed for 16th AGM - all 4 resolutions passed with requisite majority
QLINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q-Line Biotech filed the Scrutinizer's Report for its 16th AGM held on 30 September 2026 in Lucknow in physical mode. Four resolutions were put to vote and all passed with requisite majority. Adoption of Standalone and Consolidated Audited Financial Statements for FY ending 31 March 2026 received 100% approval from 31 members holding 1.72 crore shares. Re-appointment of Director Mr. Ajay Kumar Mahanty also got 100% approval. Re-appointment of Mr. Kuldeep Chowdhry got 99.99% with just 1,200 votes against. Ratification of Cost Auditor remuneration for FY 2026-27 passed with 99.99% in favour.
Routine AGM outcome. All resolutions cleared with near 100% approval. No material impact for shareholders or stock price.